This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Advanced Rare Tumours
and you are
over 16
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The standard or usual treatment for this disease may be chemotherapy or other types of treatment to slow the spread of the disease and relieve some symptoms of this cancer.

Provided treatments

  • Drug: Durvalumab
  • Drug: Tremelimumab

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02879162. The sponsor of the trial is Canadian Cancer Trials Group and it is looking for 140 volunteers for the current phase.
Official trial title:
A Phase II Study of Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours